These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33029052)

  • 1. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.
    Choudhary NS; Saigal S; Thummala S; Saraf N; Rastogi A; Bhangui P; Srinivasan T; Yadav SK; Nundy S; Soin AS
    J Clin Exp Hepatol; 2020; 10(5):442-447. PubMed ID: 33029052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
    Kashyap R; Mantry P; Sharma R; Maloo MK; Safadjou S; Qi Y; Jain A; Maliakkal B; Ryan C; Orloff M
    J Gastrointest Surg; 2009 Aug; 13(8):1480-6. PubMed ID: 19430850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study.
    Visseren T; Erler NS; Heimbach JK; Eaton JE; Selzner N; Gulamhusein A; van der Heide F; Porte RJ; van Hoek B; Alwayn IPJ; Metselaar HJ; IJzermans JNM; Darwish Murad S
    JHEP Rep; 2022 Dec; 4(12):100599. PubMed ID: 36426376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of cholestatic liver disease after living donor liver transplantation.
    Tamura S; Sugawara Y; Kaneko J; Togashi J; Matsui Y; Yamashiki N; Kokudo N; Makuuchi M
    World J Gastroenterol; 2008 Sep; 14(33):5105-9. PubMed ID: 18777585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
    Tamura S; Sugawara Y; Kaneko J; Matsui Y; Togashi J; Makuuchi M
    Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report.
    Miyagi Y; Kinjo T; Yoshizumi T; Harada N; Arakaki S; Kinjo T; Hokama A; Takatsuki M
    Surg Case Rep; 2020 Nov; 6(1):278. PubMed ID: 33130979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database.
    Kashyap R; Safadjou S; Chen R; Mantry P; Sharma R; Patil V; Maloo M; Ryan C; Marroquin C; Barry C; Ramaraju G; Maliakkal B; Orloff M
    J Gastrointest Surg; 2010 Sep; 14(9):1362-9. PubMed ID: 20617395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
    Heinemann M; Liwinski T; Adam R; Berenguer M; Mirza D; Malek-Hosseini SA; Heneghan MA; Lodge P; Pratschke J; Boudjema K; Paul A; Zieniewicz K; Fronek J; Mehrabi A; Acarli K; Tokat Y; Coker A; Yilmaz S; Karam V; Duvoux C; Lohse AW; Schramm C;
    Am J Transplant; 2022 Feb; 22(2):626-633. PubMed ID: 34605157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.
    Egawa H; Ueda Y; Ichida T; Teramukai S; Nakanuma Y; Onishi S; Tsubouchi H
    Am J Transplant; 2011 Mar; 11(3):518-27. PubMed ID: 21219581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis.
    Sierra L; Barba R; Ferrigno B; Goyes D; Diaz W; Patwardhan VR; Saberi B; Bonder A
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.
    Khettry U; Keaveny A; Goldar-Najafi A; Lewis WD; Pomfret EA; Pomposelli JJ; Jenkins RL; Gordon FD
    Hum Pathol; 2003 Nov; 34(11):1127-36. PubMed ID: 14652814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric liver transplantation for primary sclerosing cholangitis.
    Miloh T; Anand R; Yin W; Vos M; Kerkar N; Alonso E;
    Liver Transpl; 2011 Aug; 17(8):925-33. PubMed ID: 21506253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choledochoduodenostomy is associated with fewer post-transplant biliary complications compared to Roux-en-Y in primary sclerosing cholangitis patients.
    Jonica ER; Han S; Burton JR; Pomposelli JJ; Shah RJ
    Clin Transplant; 2022 May; 36(5):e14597. PubMed ID: 35043996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation for Primary Sclerosing Cholangitis: Report of a Case.
    Motomura T; Yoshizumi T; Wang H; Nagatsu A; Itoh S; Harada N; Harimoto N; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
    Transplant Proc; 2017 Jun; 49(5):1196-1198. PubMed ID: 28583556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
    Hildebrand T; Pannicke N; Dechene A; Gotthardt DN; Kirchner G; Reiter FP; Sterneck M; Herzer K; Lenzen H; Rupp C; Barg-Hock H; de Leuw P; Teufel A; Zimmer V; Lammert F; Sarrazin C; Spengler U; Rust C; Manns MP; Strassburg CP; Schramm C; Weismüller TJ;
    Liver Transpl; 2016 Jan; 22(1):42-52. PubMed ID: 26438008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
    Tibdewal P; Bhatt P; Jain A; Gupta D; Bhatia S; Shukla A
    Indian J Gastroenterol; 2019 Aug; 38(4):295-302. PubMed ID: 31515764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.